Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas

Tropical Medicine and International Health

Volumn 10, Issue 5, 2005, Pages 478-483

  Mohapatra, P K ^a   Prakash, Anil ^a   Taison, K ^b   Negmu, K ^c   Gohain, A C ^b,e   Namchoom, N S ^b   Wange, D ^b,e   Bhattacharyya, D R ^a   Goswami, B K ^a   Borgohain, B K ^d   Mahanta, J ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE   (India)

^b Nampong PHC ^*  (India)

^c Miao Community Health Centre   (India)

^d Regional Office for Health and Family Welfare (Government of India)   (India)

^e Namsai Community Health Centre   (India)

Author keywords

Antimalarial; Border area malaria; Chloroquine; Drug resistance; In vivo sensitivity; Sulphadoxine pyrimethamine; Therapeutic failure

Indexed keywords

CHLOROQUINE; FANSIDAR;

DISEASE TREATMENT; MALARIA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SMEAR; CHILD; CLINICAL PROTOCOL; DRUG CHOICE; FEMALE; HEALTH CARE POLICY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MYANMAR; PATIENT MONITORING; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG COMBINATIONS; DRUG EVALUATION; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SEX DISTRIBUTION; SULFADOXINE; TREATMENT FAILURE; TREATMENT OUTCOME;

ARUNACHAL PRADESH; ASIA; EASTERN HEMISPHERE; EURASIA; INDIA; MYANMAR; SOUTH ASIA; SOUTHEAST ASIA; WORLD;

PLASMODIUM FALCIPARUM;

EID: 21044455287     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01401.x     Document Type: Article

References (12)

1. Bloland PB (2001) Drug Resistance in Malaria. World Health Organization, Geneva (WHO/CDS/CSR/DRS/2001.4).
2. Ejov MN, Tun T, Aung S & Sein K (1999) Response of falciparum malaria to different antimalarials in Myanmar. Bulletin of the World Health Organization 77, 244-249.
3. Mohapatra PK, Prakash A, Bhattacharyya DR & Mahanta J (1998) Malaria situation in north-eastern region of India. ICMR Bulletin 28, 21-30.
4. Mohapatra PK, Prakash A, Bhattacharyya DR, Goswami BK & Mahanta J (1999) Concurrent multi-drug resistant Plasmodium falciparum from northeast India, a case report. Journal of the Association of Physicians in India 47, 823-824.
5. Mohapatra PK, Namchoom NS, Prakash A, Bhattacharyya DR, Goswami BK & Mahanta J (2003) Therapeutic efficacy of antimalarials in Plasmodium falciparum malaria in an Indo-Myanmar border area of Arunachal Pradesh. Indian Journal of Medical Research 118, 71-76.
6. NMEP (1997) Drug resistance and chemotherapy of malaria in India, an update. In: National Malaria Eradication Programme (Enhanced Malaria Control Project) (eds GPS Dhillon, GS Sonal, U Arora & J Nandi) Ministry of Health & Family Welfare, Government of India, New Delhi, pp. 14-18.
7. Sehgal PN, Sharma MID, Sharma SL & Gogai S (1975) Resistance to chloroquine in falciparum malaria in Assam state, India. Journal of Communicable Diseases 5, 175-180.
8. Smithuis FM, Monti F, Grundi M et al. (1997) Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 468-472.
9. Verdrager J (1986) Epidemiology of emergence and spread of drug resistant falciparum malaria in Southeast Asia. Southeast Asian Journal of Tropical Medicine & Public Health 17, 111-117.
10. Wernsdorfer WH & Payne D (1991) The dynamics of drug resistance in Plasmodium falciparum. Pharmacology and Therapy 50, 95-121.
11. WHO (1973) Chemotherapy of malaria and resistance to antimalarials. World Health Organization Technical Report 259, Geneva.
12. WHO (2001) Monitoring Antimalarial Drug Resistance. World Health Organization, Geneva (WHO/CDS/CSR/EPH/2002.17; WHO/CDS/RBM/2002.39).